CME Group Inc. officer Julie Winkler filed a Form 144 notice of proposed sale of 10,079 shares of CME Group common stock, with an approximate sale date of November 2, 2026.
Key Highlights
- Proposed seller: Julie Winkler, an officer of CME Group Inc., is the person for whose account the securities are to be sold.
- Shares proposed for sale: 10,079 shares of CME Group common stock, with an aggregate market value of $3,075,614.91 according to the filing.
- Shares outstanding: The filing reports 357,930,746 shares of common stock outstanding.
- Approximate sale date: November 2, 2026, through Morgan Stanley Smith Barney LLC Executive Financial Services, on NASDAQ.
- No sales in prior 3 months: The filing indicates nothing to report for securities sold during the past 3 months.
- Acquisition history: The shares to be sold were acquired from the issuer through restricted stock and performance share grants between September 16, 2020 and March 15, 2025.
CME Group Officer Julie Winkler Files Rule 144 Notice for Common Stock Sale
According to the Form 144 filing submitted on November 2, 2026, Julie Winkler, identified as an officer of CME Group Inc. (NASDAQ:CME), proposes to sell 10,079 shares of CME Group common stock. The filing lists an aggregate market value of $3,075,614.91 for the proposed sale, which is expected to take place on or around November 2, 2026. The named broker handling the transaction is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.
The filing details the acquisition history of the securities to be sold. The shares were acquired from the issuer through a series of restricted stock and performance share grants. Specifically, the filing lists acquisitions on September 16, 2020 (443 shares), September 15, 2021 (544 shares), September 16, 2021 (455 shares), March 15, 2022 (1,494 shares via performance shares), September 15, 2022 (564 shares and 487 shares in two separate grants), September 16, 2022 (471 shares), March 15, 2024 (3,578 shares via performance shares), and March 15, 2025 (2,043 shares via performance shares).
The filing states that no securities of CME Group were sold by the reporting person during the past 3 months. By signing the notice, Winkler represented, as stated in the form, that she "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed." The total shares outstanding are listed as 357,930,746.
What Was Disclosed
CME Group officer Julie Winkler filed a Form 144 proposing to sell 10,079 shares of CME Group common stock, with an aggregate market value of $3,075,614.91, through Morgan Stanley Smith Barney LLC on or around November 2, 2026, on NASDAQ.




Please wait processing your request...